Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00185 |
| Species: | Homo sapiens |
| Position : | chr2:126521490-126522490 |
| Year: | 2019 |
| Title: | Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Alzheimer disease |
| PMID: | 31727856 |
| MONDO: | MONDO:0004975 |
| Tissue: | brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | H1-derived microglia |
| Cell Type: | microglial cell |
| Cell Ontology ID: | CL:0000129 |
| Experiment Type: | Regulatory element functional validation, 3D chromatin interaction mapping; Disease-variant functional analysis |
| High Throughput Method: | ChIP-seq, ATAC-seq, PLAC-seq, RNA-seq |
| Low Throughput Method: | CRISPR-Cas9 deletion, RT-RT-qPCR, Western blot; Flow cytometry |
| Target gene : | BIN1 |
| TF name : | SPI1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| SPI1 | C-MYB transcription factor network | pid | 87 |
| SPI1 | ERK cascade ( FGF8 signaling (Mouse) ) | inoh | 17 |
| SPI1 | ERK cascade ( FGF8 signaling (Xenopus) ) | inoh | 17 |
| SPI1 | FGF8 signaling pathway(Mouse) ( FGF8 signaling (Mouse) ) | inoh | 20 |
| SPI1 | FGF8 signaling pathway(Xenopus) ( FGF8 signaling (Xenopus) ) | inoh | 18 |
| SPI1 | Glucocorticoid receptor regulatory network | pid | 85 |
| SPI1 | IL4-mediated signaling events | pid | 66 |
| SPI1 | IL4 | netpath | 75 |
| SPI1 | Interleukin signaling pathway | panther | 86 |
| SPI1 | RANKL | netpath | 84 |
| SPI1 | Regulation of retinoblastoma protein | pid | 67 |
| SPI1 | Validated targets of C-MYC transcriptional repression | pid | 63 |
| SPI1 | Pathways in cancer | kegg | 321 |
| SPI1 | Acute myeloid leukemia | kegg | 53 |
| SPI1 | Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 | wikipathways | 26 |